NOVOPEN Echo Plus Insulin Pen

Product Information

But now I can simply check my NovoPens by pressing the memory mode down or looking back on the history log on the FreeStyle LibreLink app. When your pancreas is working properly it makes small amounts of insulin all the time and releases more insulin when your blood glucose levels increase after eating. In the Swedish pilot, the pens were downloaded in the healthcare provider’s office using a kiosk (see picture below) – the goal was to improve the conversation between the person with diabetes and the healthcare provider, combining insulin data with glucose data. NovoPen ® 6 / NovoPen Echo ® Plus comes with a three-year full guarantee and Novo Nordisk will replace any pens that are faulty within that period. mmol/L) per day, with a reduction in time spent in hyperglycaemia (measured as HbA 1c >10 mmol/L) and level 2 hypoglycaemia (measured as HbA 1c <3.

NovoPen® 6 and NovoPen Echo® Plus - Novo Nordisk NovoPen® 6 and NovoPen Echo® Plus - Novo Nordisk

Once your smart insulin pen is connected to an integrated app, this information can then be sent virtually to help people manage their insulin data more easily and in one place. The kid-friendly Echo Plus allows for half-unit dosing and a maximum 30-unit injection, whereas the NovoPen 6 has a minimum dose of one unit and a maximum dose of 60 units. It has simply made a positive difference to my consultations and experiences of people in my clinic. Novo Nordisk has signed collaboration agreements with Glooko, Roche and Dexcom to support the future integration of its NovoPen 6 and NovoPen Echo Plus insulin pens with digital health solutions.

Earlier this year, Glooko received FDA clearance for a basal insulin dosing advice app, and we hope to see that come to market at some point. NovoPen ® 6 / NovoPen Echo ® Plus have been available to purchase in pharmacies from September 12 this year.

Hypodermic insulin injection pens: NovoPen Echo® Plus

Reusable Novo Nordisk smart insulin pens will launch first, followed by a Bluetooth attachment for disposable pens later in 2019.

The NovoPen 6 and NovoPen Echo Plus both feature an electronic display that shows the amount of active insulin (insulin on board or “IOB”), size of the last dose, and time since last injection. These partners (and likely more to come) will integrate insulin injection data into their apps/platforms, and in some cases, including dosing advice based on it. Emma Wilmot, consultant diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust said: “Integrating innovative technology as a routine part of diabetes care is an important step to improve diabetes care. Novo Nordisk’s smart connected pens are an example of how technology can support people living with diabetes to gain greater insight into the management of their diabetes, on their journey to becoming experts in their diabetes.

Your quick guide to using NovoPen® 6 or NovoPen Echo® Plus Your quick guide to using NovoPen® 6 or NovoPen Echo® Plus

Novo Nordisk are delighted to announce the launch of NovoPen® 6 and NovoPen Echo® Plus in Ireland – smart insulin pens that offer digital connectivity for people with diabetes. Smart insulin pens, also known as connected pens, can be used by and are beneficial to people with all forms of diabetes that inject insulin, whether you finger-prick and use blood glucose meters, or you use CGMs or flash glucose monitors. Technology is rapidly changing the way we manage and live with diabetes, mainly Type 1 diabetes, and is enabling us to manage our condition better and achieve better long-term outcomes.Our smart connected insulin pens aim to empower people to better understand their diabetes management, have more informed conversations with their doctor and ultimately improve their blood glucose control. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site. Glooko: In January 2017,Novo Nordisk and Glooko announced a partnershipto develop digital diabetes tools together. We firmly believe that this will help more people realise the full benefit of our innovative medicines and begin to ease the mental burden of diabetes treatment for those individuals. The company is planning to commercially launch these connected insulin pens in the first quarter of next year across limited markets.